Libera Bio has announced that it has closed its Seed Round to advance its MPN Technology® into enabling studies and towards the clinic.
Investors include Xesgalicia, Semola Tech Ventures, ROSP Coruña Participaciones Empresariales, S.L., and Nowture
cloud technology axon
tuTECHÔ, empresa social que lucha contra el sinhogarismo en España, ...
Capital-Riesgo.es
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Capital-Riesgo.es - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory